1. Home
  2. ALT vs GRRR Comparison

ALT vs GRRR Comparison

Compare ALT & GRRR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • GRRR
  • Stock Information
  • Founded
  • ALT 1997
  • GRRR 2001
  • Country
  • ALT United States
  • GRRR United Kingdom
  • Employees
  • ALT N/A
  • GRRR N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • GRRR Computer Software: Prepackaged Software
  • Sector
  • ALT Health Care
  • GRRR Technology
  • Exchange
  • ALT Nasdaq
  • GRRR Nasdaq
  • Market Cap
  • ALT 348.6M
  • GRRR 384.2M
  • IPO Year
  • ALT N/A
  • GRRR N/A
  • Fundamental
  • Price
  • ALT $4.00
  • GRRR $15.80
  • Analyst Decision
  • ALT Strong Buy
  • GRRR Buy
  • Analyst Count
  • ALT 7
  • GRRR 1
  • Target Price
  • ALT $16.50
  • GRRR $18.00
  • AVG Volume (30 Days)
  • ALT 2.7M
  • GRRR 1.6M
  • Earning Date
  • ALT 11-07-2025
  • GRRR 08-14-2025
  • Dividend Yield
  • ALT N/A
  • GRRR N/A
  • EPS Growth
  • ALT N/A
  • GRRR N/A
  • EPS
  • ALT N/A
  • GRRR N/A
  • Revenue
  • ALT $20,000.00
  • GRRR $93,325,178.00
  • Revenue This Year
  • ALT N/A
  • GRRR $36.14
  • Revenue Next Year
  • ALT N/A
  • GRRR $27.83
  • P/E Ratio
  • ALT N/A
  • GRRR N/A
  • Revenue Growth
  • ALT N/A
  • GRRR 18.22
  • 52 Week Low
  • ALT $2.90
  • GRRR $3.71
  • 52 Week High
  • ALT $11.16
  • GRRR $44.15
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.72
  • GRRR 36.78
  • Support Level
  • ALT $3.83
  • GRRR $16.44
  • Resistance Level
  • ALT $4.15
  • GRRR $17.29
  • Average True Range (ATR)
  • ALT 0.17
  • GRRR 1.00
  • MACD
  • ALT 0.00
  • GRRR -0.25
  • Stochastic Oscillator
  • ALT 58.90
  • GRRR 5.00

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About GRRR Gorilla Technology Group Inc.

Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.

Share on Social Networks: